Deployment
Hugo RAS at United States
Medtronic (NYSE: MDT; founded 1949 in Minneapolis, with legal headquarters in Dublin) makes the Hugo robotic-assisted surgery system, the late-market big-medtech challenger to Intuitive's da Vinci. Hugo is a modular multi-port teleoperated platform that received its European CE mark for urologic and gynecologic procedures on October 11, 2021, and, in the key regulatory milestone, US FDA clearance on December 3, 2025 for urologic procedures only, including prostatectomy, nephrectomy, and cystectomy, backed by the Expand URO investigational-device-exemption trial of 137 patients that met its primary safety and efficacy endpoints and was presented at AUA 2025. General-surgery and gynecologic US indications are planned submissions but are not yet cleared. The registry records Hugo at commercial maturity: it has been CE-marked and commercially used outside the US across more than 30 countries since 2021 and is now US-cleared for urology and entering US rollout. Medtronic discloses no specific system installed-base count, citing only tens of thousands of procedures across 30-plus countries, so the unit count is left as an honest absence rather than invented. On AI substance, Hugo is a master-slave teleoperated system whose Touch Surgery digital and video ecosystem is analytics and recording rather than autonomy, with no verified shipped intraoperative AI guidance.
Hugo RAS by Medtronic · Catalog entry · 2 sources · not yet field-verified
Machine-readable surfaces
- Markdown mirror: /deployments/medtronic-hugo-us.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/robots/b4ca00cf-b5af-4abe-b785-dc77fbad0582
- Data documentation: /data
- Query this programmatically: Deploy MCP
Footage
Medtronic's product animation of its Hugo RAS system, showing the modular arm-carts and open console. The animation depicts the system, not an autonomous capability; the arms are surgeon-driven.
Medtronic's footage of a first patient procedure on its Hugo RAS robotic-assisted surgery system. The surgeon teleoperates from a master console; the system is never autonomous.
Medtronic's introduction of its Hugo RAS robotic-assisted surgery system. Hugo is teleoperated by a surgeon from a console; its US FDA clearance covers urologic procedures.
- Trust tier
- Catalog entry · 2 sources · not yet field-verified
- Last updated
- 2026-06-12
- Model
- Hugo RAS
- Company
- Medtronic
- Location
- United States
- Status
- operational
- First seen
- 2024-01-01
- ID
b4ca00cf-b5af-4abe-b785-dc77fbad0582
Sources (2)
- Medtronic Hugo RAS — US product page · https://www.medtronic.com/us-en/healthcare-professionals/products/surgical/robotic-assisted-surgery/hugo-ras-system.html
- Medtronic Hugo FDA clearance, December 2023 · https://news.medtronic.com/2023-12-12-Medtronic-Receives-FDA-Clearance-for-Hugo-RAS-System
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-06-12
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-06-12
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 2
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Hugo RAS at United States.Common questions
- What is the Hugo RAS deployment at United States?
- Hugo RAS, built by Medtronic, is recorded as a deployment at United States on the DEPLOY registry. Medtronic operates the deployment directly.
- Who operates Hugo RAS at United States?
- Medtronic, the manufacturer of Hugo RAS, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
- When did the Hugo RAS deployment at United States go live?
- The deployment is recorded as starting January 1, 2024 on the DEPLOY registry. Earlier activity may exist but is not yet sourced.
- Have there been incidents at the Hugo RAS deployment at United States?
- No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.
Deploy Watch
Track this deployment.
We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.